Table 1.
Age (years) | 49 (19–92) |
Sex (female vs males) | 128/ 156 (45.1% vs 54.9%) |
Co-morbid diseases | |
Hypertension | 72 (24.5%) |
Diabetes mellitus | 36 (12.7%) |
Chronic obstructive pulmonary disease | 30 (10.6%) |
Coronary artery disease | 17 (6.0%) |
Congestive heart failure | 5 (1.8%) |
Solid malignancy | 26 (9.2%) |
Hematological malignancy | 7 (2.5%) |
Clinical course | |
Severe vs mild | 94/190 (33.1% vs 66.9%) |
Symptoms | |
Dry cough | 170 (59.9%) |
Fever | 154 (54.2%) |
Myalgia | 145 (51.1%) |
Dyspnea | 94 (33.1%) |
Nausea/vomitus | 30 (10.6%) |
Diarrhea | 23 (8.1%) |
Anosmia/dysgeusia | 13 (4.6%) |
Sputum | 1 (0.4%) |
Physical examination findings on admission | |
Fever | 94/190 (33.1%/66.9%) |
Body temperature | 36.6 (35–40) |
Saturation pO2 (peripheral) | 97 (87–100) |
Systolic blood pressure | 130 (90–240) |
Diastolic blood pressure | 75 (50–100) |
Pulse (/min) | 92 (60–160) |
Respiratory rate (/min) | 16 (12–40) |
Laboratory evaluation | |
pH | 7.41 (7.1–8.1) |
pO2 | 62 (35–86) |
pCO2 | 40 (23–63) |
HCO3 | 24 (14–35) |
Lactate | 1.5 (1–7) |
Hemoglobin (g/dL) | 13.2 (6.3–18) |
Leukocyte (/mm3) | 7130 (930–28,300) |
Thrombocyte (/mm3) | 241,000 (66000–576,000) |
Lymphocyte (/mm3) | 1390 (270–4520) |
Lymphopenia (<800/mm3) | 57 (20.1%) |
BUN (mg/dL) | 13 (5–107) |
Creatinine (mg/dL) | 0.8 (0.4–6) |
Glucose (mg/dL) | 106 (68–496) |
AST (U/L) | 21 (10–409) |
ALT (U/L) | 21 (2–493) |
GGT (U/L) | 21 (4–744) |
ALP (U/L) | 73 (33–400) |
LDH (U/L) | 194 (78–731) |
Total protein (g/dL) | 7.4 (5–9) |
Albumin (g/dL) | 4.0 (2–5) |
CRP (mg/dL) | 19.5 (1–363) |
Procalcitonin (ng/mL) | 0.06 (0.2–50.0) |
Ferritin | 166 (6–6656) |
D-dimer | 58 (5–35,000) |
Troponin-T | 4 (3–848) |
Fibrinogen | 423 (151–1053) |
INR | 0.9 (0.8–3.8) |
aPTT | 28 (21–53) |
Follow-up | |
Mortality (at 28 days) | 9 (3.2%) |
Intensive care unit need | 16 (6.3%) |
Data are given as numbers (%) or median (interquartile range).